Tag Archives: Plan

With pivot to less-rare diseases, Alexion needs a new sticker-price plan, CEO says

SAN FRANCISCO—In 2019, Alexion is looking to pivot from an ultrarare-disease company to a rare-disease company—and it knows its pricing strategy has to change. With its top-selling therapy, Soliris, the company is moving into new diseases that aren’t nearly as rare as its previous targets. The drug recently nabbed an approval in generalized myasthenia gravis and is looking… Read More »

How Juul's plan to teach students about vaping went up in smoke

The company abandoned these efforts in May, not long after its initial outreach, in response to a backlash from health and education advocates. “Under no circumstance should anybody from the tobacco, nicotine, vaping industries be involved in or implementing tobacco prevention programs,” said Bonnie Halpern-Felsher, professor of pediatrics in Stanford University’s Division of Adolescent Medicine.… Read More »